BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26446477)

  • 1. A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA.
    Amber KT; Bloom R; Hertl M
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):72-7. PubMed ID: 26446477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
    Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
    Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA.
    Bekou V; Thoma-Uszynski S; Wendler O; Uter W; Schwietzke S; Hunziker T; Zouboulis CC; Schuler G; Sorokin L; Hertl M
    J Invest Dermatol; 2005 Apr; 124(4):732-40. PubMed ID: 15816831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid.
    Natsuga K; Nishie W; Shinkuma S; Moriuchi R; Shibata M; Nishimura M; Hashimoto T; Shimizu H
    Br J Dermatol; 2010 Mar; 162(3):513-7. PubMed ID: 19751242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid: Ocular and Other Sites Compared.
    Dart J; Setterfield J; Groves RW; Mee JB; Diercks GFH; Pas HH; Minassian D;
    Ophthalmology; 2021 Mar; 128(3):372-382. PubMed ID: 32745569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
    Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Immunological Studies of 332 Japanese Patients Tentatively Diagnosed as Anti-BP180-type Mucous Membrane Pemphigoid: A Novel BP180 C-terminal Domain Enzyme-linked Immunosorbent Assay.
    Yasukochi A; Teye K; Ishii N; Hashimoto T
    Acta Derm Venereol; 2016 Aug; 96(6):762-7. PubMed ID: 26984589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.
    Hayashi I; Shinkuma S; Shimizu S; Natsuga K; Ujiie H; Yasui C; Tsuchiya K; Nishie W; Shimizu H
    Br J Dermatol; 2012 May; 166(5):1116-20. PubMed ID: 22182184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid.
    Bernard P; Antonicelli F; Bedane C; Joly P; Le Roux-Villet C; Duvert-Lehembre S; Rousselle P; Prost-Squarcioni C
    JAMA Dermatol; 2013 May; 149(5):533-40. PubMed ID: 23426192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 alpha-subunit.
    Lazarova Z; Yee C; Lazar J; Yancey KB
    Clin Immunol; 2001 Oct; 101(1):100-5. PubMed ID: 11580232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of mucous membrane pemphigoid with IgG antibodies against all the alpha3, beta3 and gamma2 subunits of laminin-332 and BP180 C-terminal domain, associated with pancreatic cancer.
    Demitsu T; Yoneda K; Iida E; Sasaki K; Umemoto N; Kakurai M; Wakatabi K; Yamada T; Ohyama B; Hashimoto T
    Clin Exp Dermatol; 2009 Dec; 34(8):e992-4. PubMed ID: 19832858
    [No Abstract]   [Full Text] [Related]  

  • 13. Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid.
    Ali S; Kelly C; Challacombe SJ; Donaldson AN; Dart JK; Gleeson M; ; Setterfield JF
    Br J Dermatol; 2016 May; 174(5):1022-9. PubMed ID: 26676445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid.
    Chiorean R; Danescu S; Virtic O; Mustafa MB; Baican A; Lischka A; Hashimoto T; Kariya Y; Koch M; Sitaru C
    Orphanet J Rare Dis; 2018 Jul; 13(1):111. PubMed ID: 29980216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
    Raffin D; Delaplace M; Roussel A; Estève E
    Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of mucous membrane pemphigoid with IgG antibodies against the β3 and γ2 subunits of laminin-332, and the C-terminal domain of BP180.
    Yasumizu M; Imanishi H; Morita S; Fukuda A; Tateishi C; Koga H; Hashimoto T; Tsuruta D
    Int J Dermatol; 2018 Jan; 57(1):86-88. PubMed ID: 29130487
    [No Abstract]   [Full Text] [Related]  

  • 17. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
    Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of pemphigus herpetiformis with IgG antibodies to desmocollin 1 and pemphigoid with IgG antibodies to BP180 C-terminal domain and laminin γ2.
    Ohata C; Higashi Y; Yamagami J; Koga H; Ishii N; Kanekura T; Furumura M; Hashimoto T
    JAMA Dermatol; 2013 Apr; 149(4):502-4. PubMed ID: 23715433
    [No Abstract]   [Full Text] [Related]  

  • 19. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
    Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
    J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies.
    Kuang W; Qian H; Zhang Q; Li W; Hashimoto T; Zeng X; Li X
    Front Immunol; 2022; 13():903174. PubMed ID: 35720393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.